EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseÜbersichtsarbeit

Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis

Mina Ehab Ayad iD, Shiyi Yu, Safia El Shennawy, Enaam Ali Al Mowafy, Nur-Fazimah Sahran, Rawan Elwalid-Jad, Yeong Yeh Lee iD

Journal of Gastroenterology and Hepatology · 2026-07 · 41 (7) · 1994-2005

DOI: 10.1111/jgh.70421 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 08.05.2026. Verfasst von Mina Ehab Ayad und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Probiotics. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim Postbiotics, preparations of inanimate microorganisms and/or their components with health benefits, may offer potential advantages in the management of IBS, but evidence remains limited. We conducted the first systematic review and meta‐analysis to assess the efficacy and safety of postbiotics in adults with IBS.

Methods

PubMed, Scopus, Embase, and Web of Science were searched from inception to August 2025 for randomized controlled trials (RCTs) comparing postbiotics with placebo in adults diagnosed with IBS by Rome III or IV criteria. Primary outcomes were changes in the IBS Symptom Severity Scale (IBS‐SSS) and achievement of ≥ 30% abdominal pain reduction. Secondary outcomes included quality of life (QoL) and treatment‐emergent adverse events (TEAEs). Risk of bias was assessed using Cochrane RoB 2.0 and certainty of evidence using GRADE. Meta‐analyses were conducted using RevMan 5.4.

Results

Four RCTs including 1062 participants were analyzed. Postbiotics significantly reduced IBS‐SSS scores compared with placebo (standardized mean difference [SMD] − 1.36, 95% CI −1.75 to −0.97; p < 0.00001). Postbiotics increased the likelihood of achieving a clinically meaningful pain response (risk ratio [RR] 2.46, 95% CI 1.96–3.57; p < 0.00001). QoL improved with oral capsule formulations (SMD 0.84, 95% CI 0.67–1.01; I 2 = 0%), but not when an enema‐based study was included. TEAE rates were similar between groups (RR 0.68, 95% CI 0.34–1.35; p = 0.27). Heterogeneity was moderate to substantial. Certainty of evidence was low.

Conclusions

Postbiotics may improve IBS symptom severity and abdominal pain, with oral formulations showing potential QoL benefits and comparable safety to placebo. Larger, standardized RCTs are required to confirm these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeProbioticsHumansQuality of LifeTreatment OutcomeRandomized Controlled Trials as TopicSeverity of Illness IndexAbdominal PainAdult

Stichwörter der Autor:innen

ghost bioticsgut–brain axisirritable bowel syndromenovel therapiesparabioticspostbiotics

Autor:innen und Institutionen

  • School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Malaysia.
  • GI Function and Motility Unit, Hospital Pakar Universiti Sains Malaysia, Kubang Kerian, Malaysia.
  • Department of Gastroenterology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Faculty of Medicine, Tanta University, Egypt.
  • Tropical Medicine Department, Ain Shams University, Egypt.

ORCID-Profile: Mina Ehab Ayad, Yeong Yeh Lee

Zitieren

APA

Ayad, M. E., Yu, S., El Shennawy, S., Al Mowafy, E. A., Sahran, N. F., Elwalid-Jad, R., & Lee, Y. Y. (2026). Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology, 41(7), 1994-2005. https://doi.org/10.1111/jgh.70421

Vancouver

Ayad ME, Yu S, El Shennawy S, Al Mowafy EA, Sahran NF, Elwalid-Jad R, et al. Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis. Journal of Gastroenterology and Hepatology. 2026;41(7):1994-2005. doi:10.1111/jgh.70421

BibTeX
@article{Ayad2026,
  author = {Ayad, Mina Ehab and Yu, Shiyi and El Shennawy, Safia and Al Mowafy, Enaam Ali and Sahran, Nur-Fazimah and Elwalid-Jad, Rawan and Lee, Yeong Yeh},
  title = {Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta‐Analysis},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {7},
  pages = {1994--2005},
  doi = {10.1111/jgh.70421}
}
Kostenlos starten →